{
    "organizations": [],
    "uuid": "27080ba009d3380ad7d13a960dc1e0bf0826dbac",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-valeritas-says-v-go-insulin-delive/brief-valeritas-says-v-go-insulin-delivery-device-demonstrates-positive-clinical-benefits-in-type-2-diabetes-patients-idUSFWN1SU0ME",
    "ord_in_thread": 0,
    "title": "BRIEF-Valeritas’ Says V-Go Insulin Delivery Device Demonstrates Positive Clinical Benefits In Type 2 Diabetes Patients",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 23 (Reuters) - Valeritas Holdings Inc:\n* VALERITAS’ V-GO® WEARABLE INSULIN DELIVERY DEVICE DEMONSTRATES POSITIVE CLINICAL AND ECONOMIC BENEFITS IN PATIENTS WITH TYPE 2 DIABETES Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-23T19:17:00.000+03:00",
    "crawled": "2018-05-24T20:14:58.003+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "valeritas",
        "holding",
        "inc",
        "valeritas",
        "wearable",
        "insulin",
        "delivery",
        "device",
        "demonstrates",
        "positive",
        "clinical",
        "economic",
        "benefit",
        "patient",
        "type",
        "diabetes",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}